Literature DB >> 15666038

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.

C Barcia1, V Bautista, A Sánchez-Bahillo, E Fernández-Villalba, B Faucheux, M Poza y Poza, A Fernandez Barreiro, E C Hirsch, M-T Herrero.   

Abstract

The degeneration of nigral dopaminergic neurons in Parkinson's disease is believed to be associated with a glial reaction and inflammatory changes. In turn, local factors may induce changes in vascularization and contribute to neuronal vulnerability. Among these factors, Vascular Endothelial Growth Factor (VEGF) is released in adults under pathological conditions and is thought to induce angiogenesis. In order to determine whether changes in brain vasculature are observed in the affected brain regions in parkinsonism, we quantitatively analysed the VEGF-expressing cells and blood vessels in the substantia nigra of monkeys rendered parkinsonian by MPTP injection and compared the results with those obtained in control monkeys. Using stereological methods, we observed an increase in the number of VEGF-expressing neurons and an increase of the number of blood vessels and their volume occupying the substantia nigra pars compacta of monkeys rendered parkinsonian by chronic MPTP intoxication. These changes in vascularization may therefore modify the neuronal availability of blood nutrients, blood cells or toxic substances and neuronal susceptibility to parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15666038     DOI: 10.1007/s00702-004-0256-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  51 in total

1.  Neuronal-vascular relationships in the raphe nuclei, locus coeruleus, and substantia nigra in primates.

Authors:  D L Felten; K A Crutcher
Journal:  Am J Anat       Date:  1979-08

2.  Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining.

Authors:  A M Graybiel; C W Ragsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

Review 3.  The role of the immune system in neurodegenerative disorders.

Authors:  E G McGeer; P L McGeer
Journal:  Mov Disord       Date:  1997-11       Impact factor: 10.338

4.  Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain.

Authors:  Beatrice Nico; Patrizia Corsi; Angelo Vacca; Luisa Roncali; Domenico Ribatti
Journal:  Brain Res       Date:  2002-10-25       Impact factor: 3.252

5.  Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal.

Authors:  K L Jin; X O Mao; D A Greenberg
Journal:  J Mol Neurosci       Date:  2000-06       Impact factor: 3.444

6.  VEGF protects human cerebral hybrid neurons from in vitro ischemia.

Authors:  Moon-Ku Han; Manho Kim; So Yon Bae; Lami Kang; So Young Han; Yong-Seok Lee; Jeong Ho Rha; Seung U Kim; Jae-Kyu Roh
Journal:  Neuroreport       Date:  2004-04-09       Impact factor: 1.837

7.  Involvement of platelets in tumour angiogenesis?

Authors:  H M Pinedo; H M Verheul; R J D'Amato; J Folkman
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

8.  Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.

Authors:  M T Herrero; E C Hirsch; A Kastner; M R Luquin; F Javoy-Agid; L M Gonzalo; J A Obeso; Y Agid
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

Review 9.  Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?

Authors:  E C Hirsch
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

10.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  31 in total

Review 1.  Microglial interactions with the neurovascular system in physiology and pathology.

Authors:  Xiaoliang Zhao; Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2018-02-01       Impact factor: 3.964

2.  Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum.

Authors:  Xuesong Chen; Xun Lan; Ian Roche; Rugao Liu; Jonathan D Geiger
Journal:  J Neurochem       Date:  2008-09-20       Impact factor: 5.372

3.  Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration.

Authors:  C Requejo; J A Ruiz-Ortega; H Bengoetxea; A Garcia-Blanco; E Herrán; A Aristieta; M Igartua; L Ugedo; J L Pedraz; R M Hernández; J V Lafuente
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

4.  An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity.

Authors:  Aditiben Patel; Giuseppe V Toia; Kalea Colletta; Brinda Desai Bradaric; Paul M Carvey; Bill Hendey
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

5.  Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.

Authors:  Brinda Desai Bradaric; Aditiben Patel; Julie A Schneider; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2011-07-12       Impact factor: 3.575

6.  Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.

Authors:  C Requejo; J A Ruiz-Ortega; H Bengoetxea; A García-Blanco; E Herrán; A Aristieta; M Igartua; J L Pedraz; L Ugedo; R M Hernández; J V Lafuente
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

Review 7.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

Review 8.  The blood-brain barrier in neurodegenerative disease: a rhetorical perspective.

Authors:  Paul M Carvey; Bill Hendey; Angela J Monahan
Journal:  J Neurochem       Date:  2009-07-31       Impact factor: 5.372

9.  Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.

Authors:  Shigeki Hirano; Kotaro Asanuma; Yilong Ma; Chengke Tang; Andrew Feigin; Vijay Dhawan; Maren Carbon; David Eidelberg
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

10.  A cross-study transcriptional analysis of Parkinson's disease.

Authors:  Greg T Sutherland; Nicholas A Matigian; Alistair M Chalk; Matthew J Anderson; Peter A Silburn; Alan Mackay-Sim; Christine A Wells; George D Mellick
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.